ERBB2 and ovarian serous adenocarcinoma: The present study investigated the impact of the expression of SLCO and related genes coding for ABC-transporters, PXR, ESR1/2, and HER-2 in serous ovarian cancer patients treated with debulking surgery and platinium- and taxane-based chemotherapy.